These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 2970811)
1. The in vivo effect of triethylphosphine gold (auranofin), sodium aurothiomalate and azathioprine on lymphocyte subsets of patients with rheumatoid arthritis. Pedersen BK; Abom B Allergy; 1988 Jul; 43(5):396-8. PubMed ID: 2970811 [TBL] [Abstract][Full Text] [Related]
2. The in vivo effect of triethylphosphine gold (auranofin), sodium aurothiomalate and azathioprine on natural killer cell activity of patients with rheumatoid arthritis. Abom B; Pedersen BK Clin Exp Rheumatol; 1987; 5(1):47-52. PubMed ID: 3109798 [TBL] [Abstract][Full Text] [Related]
3. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate. Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711 [TBL] [Abstract][Full Text] [Related]
4. Erythrocyte membrane gold levels after treatment with auranofin and sodium aurothiomalate. Iqbal MS; Saeed M; Taqi SG Biol Trace Elem Res; 2008; 126(1-3):56-64. PubMed ID: 18649049 [TBL] [Abstract][Full Text] [Related]
5. The effects of auranofin and gold sodium aurothiomalate on the chemiluminescent response of stimulated synovial tissue cells from patients with rheumatoid arthritis. Harth M; McCain GA; Orange JF J Rheumatol; 1985 Oct; 12(5):881-4. PubMed ID: 3936929 [TBL] [Abstract][Full Text] [Related]
6. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study. Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483 [TBL] [Abstract][Full Text] [Related]
7. Immunological studies in patients with rheumatoid arthritis receiving azathioprine and myocrisin in combination. Lewis P; Hazleman BL; Park JR; Bulgen DY; Franks D; Hurd C; Brown DL Clin Rheumatol; 1982 Sep; 1(3):168-75. PubMed ID: 6821381 [TBL] [Abstract][Full Text] [Related]
8. Oral gold: a comparison with placebo and with intramuscular sodium aurothiomalate. Lewis D; Capell HA Clin Rheumatol; 1984 Mar; 3 Suppl 1():83-96. PubMed ID: 6432418 [TBL] [Abstract][Full Text] [Related]
9. A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritis. Capell HA; Lewis D; Carey J Ann Rheum Dis; 1986 Sep; 45(9):705-11. PubMed ID: 3094463 [TBL] [Abstract][Full Text] [Related]
10. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Subsets of responses. Ward JR; Williams HJ; Boyce E; Egger MJ; Reading JC; Samuelson CO Am J Med; 1983 Dec; 75(6A):133-7. PubMed ID: 6419595 [TBL] [Abstract][Full Text] [Related]
11. Failure of sodium aurothiomalate and triethyl phosphine gold to cause renal tubular injury in rheumatoid arthritis: implications for the aetiology of gold-related nephropathy. Crisp AJ; Coughlan RJ; Clark B; Mackintosh D; Panayi GS; Sweny P; Hopper J; Varghese Z Clin Rheumatol; 1983 Sep; 2(3):273-6. PubMed ID: 6432404 [TBL] [Abstract][Full Text] [Related]
12. Gold(I) ion and the phosphine ligand are necessary for the anti- Ma CI; Tirtorahardjo JA; Schweizer SS; Zhang J; Fang Z; Xing L; Xu M; Herman DA; Kleinman MT; McCullough BS; Barrios AM; Andrade RM Microbiol Spectr; 2024 Feb; 12(2):e0296823. PubMed ID: 38206030 [TBL] [Abstract][Full Text] [Related]
13. Gold levels produced by treatment with auranofin and sodium aurothiomalate. Lewis D; Capell HA; McNeil CJ; Iqbal MS; Brown DH; Smith WE Ann Rheum Dis; 1983 Oct; 42(5):566-70. PubMed ID: 6414387 [TBL] [Abstract][Full Text] [Related]
14. Partial cross-resistance between auranofin and sodium aurothiomalate in cultured human cells. Rugstad HE; Glennås A Scand J Rheumatol; 1988; 17(3):175-81. PubMed ID: 3140371 [TBL] [Abstract][Full Text] [Related]
15. [Comparative study of the effects of auranofin and aurothiomalate on laboratory and clinical indicators in patients with rheumatoid arthritis]. Vlak T; Stambuk B Reumatizam; 1998; 46(1):7-19. PubMed ID: 9921004 [TBL] [Abstract][Full Text] [Related]
16. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Ward JR; Williams HJ; Egger MJ; Reading JC; Boyce E; Altz-Smith M; Samuelson CO; Willkens RF; Solsky MA; Hayes SP Arthritis Rheum; 1983 Nov; 26(11):1303-15. PubMed ID: 6416259 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of human phospholipase C by aurothiomalate and (triethylphosphine) gold complexes. Märki F; Stanton JL Arzneimittelforschung; 1992 Mar; 42(3):328-33. PubMed ID: 1353962 [TBL] [Abstract][Full Text] [Related]
18. Treatment with auranofin in patients with rheumatoid arthritis, previously experiencing drug related side effects to sodium aurothiomalate. Davis P; Landon M J Rheumatol; 1985 Jun; 12(3):622. PubMed ID: 3930724 [No Abstract] [Full Text] [Related]
19. Effects of gold compounds on function of phagocytic cells. Comparative inhibition of activated polymorphonuclear leukocytes and monocytes from rheumatoid arthritis and control subjects. Davis P; Johnston C Inflammation; 1986 Sep; 10(3):311-20. PubMed ID: 3017859 [TBL] [Abstract][Full Text] [Related]
20. Comparison between sodium aurothiomalate and auranofin in rheumatoid arthritis. Results of a two-year open randomized study. Harth M; Davis P; Thompson JM; Menard H; Beaudet F Scand J Rheumatol; 1987; 16(3):177-84. PubMed ID: 3110944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]